Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01628549 · ClinicalTrials.gov registry record · Phase 2
Double-Blind, Placebo-Controlled Study to Evaluate 3 Doses of a Novel Tetracycline in the Treatment of Facial Acne Vulgaris
A Phase 2 study, sponsored by Almirall, S.A..
- Completed
- Registry status
- Phase 2
- Development phase
- 285
- Enrollment target
NCT01628549: Completed Phase 2 study, sponsored by Almirall, S.A..
NCT01628549 is a Phase 2 study that has completed, run by Almirall, S.A.. The registered enrollment target is 285 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (114% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01628549, a Phase 2 study, has completed, sponsored by Almirall, S.A..
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 285 participants
- Enrollment target
Study Summary
To evaluate the safety and effectiveness of 3 strengths of P005672-HCl compared to placebo for the treatment of moderate to severe facial acne vulgaris.
Interventions
- DRUG Placebo
- DRUG 50 mg P005672-HCl
- DRUG 100 mg P005672-HCl
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 285 participants |
| Start Date | 2012-06-30 |
| Est. Completion | 2013-01-31 |
| Phase | Phase 2 |
What the finished NCT01628549 record still lists
NCT01628549 is an interventional study that assigns participants to a tested intervention. The registered 285 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (114% higher).
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT01628549 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01628549 about?
NCT01628549 is a clinical study titled "Double-Blind, Placebo-Controlled Study to Evaluate 3 Doses of a Novel Tetracycline in the Treatment of Facial Acne Vulgaris". To evaluate the safety and effectiveness of 3 strengths of P005672-HCl compared to placebo for the treatment of moderate to severe facial acne vulgaris.
What is the current status of trial NCT01628549?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 285 participants. The study started on 2012-06-30. Estimated completion is 2013-01-31.
What interventions are being tested in trial NCT01628549?
The interventions under investigation include: Placebo (DRUG), 50 mg P005672-HCl (DRUG), 100 mg P005672-HCl (DRUG).
Who is sponsoring clinical trial NCT01628549?
This trial is sponsored by Almirall, S.A., which has 19 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01628549's enrollment target sits among peer trials
285 192nd of 2000 higher than 1,806 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03412877 · 285 participants · Phase 2
Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer
- NCT04537936 · 285 participants · NA
Psychotherapy Intervention for Latinos With Adv Cancer
- NCT04965675 · 285 participants · Phase 3
A Study With Eptinezumab in Adolescents (12-17 Years) With Chronic Migraine
- NCT05320835 · 285 participants · NA
A Setting Focus Overdose Prevention Intervention
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI